Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement - News Summed Up

Impax Laboratories and Amneal Pharmaceuticals Near Merger Agreement


Impax Laboratories Inc. and Amneal Pharmaceuticals LLC are close to agreement on a merger that would create the nation’s fifth-largest generic-drug company by revenue, according to people familiar with the matter. The companies are in advanced negotiations on an all-stock deal that would hand Impax shareholders 25% of a new, publicly traded company and owners of closely held Amneal the remainder, the people said. The combined company is expected to be worth $6.4 billion, or about $9 billion with debt, some of the people said.


Source: Wall Street Journal October 16, 2017 21:24 UTC


Loading...
Loading...